PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2005 | 1 | 79-94
Article title

Adeno-associated virus vectors in gene therapy

Content
Title variants
Languages of publication
PL
Abstracts
EN
The development of targeted vectors, capable of tissue-specific transduction, remains one of the most important aims of vector modification for gene therapy applications. The gaining popularity of recombinant vectors based on adeno-associated viruses (rAAV) in gene therapy can be attributed to their lack of pathogenicity, added safety due to their replication defectiveness, relatively low immunogenicity and their ability to mediate long-term expression in a variety of tissues. The major shortcoming of these vectors is their small packaging capacity. AAV vectors have already broad utility in the therapy of many diseases, including neurological disorders and various types of cancer. Moreover, they can also serve as transfer vehicles for DNA vaccines.
Journal
Year
Issue
1
Pages
79-94
Physical description
References
Document Type
REVIEW
Publication order reference
Kinga Kamieniarz, Zaklad Wirusologii Molekularnej, Instytut Biologii Molekularnej i Biotechnologii, Uniwersytet im. Adama Mickiewicza, ul. Miedzychodzka 5, 60-371 Poznan, Poland
YADDA identifier
bwmeta1.element.element-from-psjc-a3b19625-1cae-34d9-8997-fc9f8126bd9f
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.